Variant report
Variant | rs2053765 |
---|---|
Chromosome Location | chr2:46669702-46669703 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000241791 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs11125074 | 0.91[ASN][1000 genomes] |
rs11125077 | 0.94[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs12619420 | 0.81[AFR][1000 genomes];0.87[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs12986585 | 0.81[ASN][1000 genomes] |
rs12994892 | 0.84[ASN][1000 genomes] |
rs13009087 | 0.93[AFR][1000 genomes];0.97[AMR][1000 genomes];0.95[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs13017856 | 0.84[AMR][1000 genomes];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13018019 | 0.84[AMR][1000 genomes];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13018477 | 0.80[AFR][1000 genomes];0.86[AMR][1000 genomes];0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs13025174 | 0.81[AFR][1000 genomes];0.88[AMR][1000 genomes];0.90[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs13025967 | 0.80[EUR][1000 genomes] |
rs13032473 | 0.83[AFR][1000 genomes];0.86[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs13033917 | 0.90[EUR][1000 genomes] |
rs1447565 | 0.82[ASN][1000 genomes] |
rs1530625 | 0.82[AMR][1000 genomes];0.91[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs1530627 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1530628 | 0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1542271 | 0.82[AMR][1000 genomes];0.86[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs1597041 | 0.92[AFR][1000 genomes];0.99[AMR][1000 genomes];0.97[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1868080 | 0.92[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs1868096 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs2084345 | 0.95[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs2121697 | 0.82[AFR][1000 genomes];0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs2121700 | 0.80[EUR][1000 genomes] |
rs2166745 | 0.81[ASN][1000 genomes] |
rs2197698 | 0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs34186951 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs3814047 | 0.83[AFR][1000 genomes];0.88[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs3814048 | 0.89[EUR][1000 genomes] |
rs3863000 | 0.87[EUR][1000 genomes] |
rs4366955 | 0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4413204 | 0.80[ASN][1000 genomes] |
rs4456747 | 0.83[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs4953373 | 0.82[AMR][1000 genomes];0.89[ASN][1000 genomes] |
rs4953374 | 0.82[ASN][1000 genomes] |
rs4953377 | 0.91[AMR][1000 genomes];0.93[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs4953381 | 0.94[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs4953384 | 0.90[EUR][1000 genomes] |
rs4953385 | 0.83[AFR][1000 genomes];0.88[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs6544894 | 0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs6715279 | 0.81[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs6726089 | 0.81[ASN][1000 genomes] |
rs6728611 | 0.85[AFR][1000 genomes];0.83[AMR][1000 genomes];0.91[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs6728847 | 0.85[AFR][1000 genomes];0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6737959 | 0.92[AFR][1000 genomes];0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs7556828 | 0.89[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7559484 | 0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7562332 | 0.84[AMR][1000 genomes];0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7565770 | 0.84[AFR][1000 genomes];0.84[AMR][1000 genomes];0.89[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs7565850 | 0.83[EUR][1000 genomes] |
rs7571742 | 0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7587138 | 0.87[AMR][1000 genomes];0.84[ASN][1000 genomes] |
rs7588586 | 0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7588938 | 0.84[AMR][1000 genomes];0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7598507 | 0.96[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7598584 | 0.96[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7598712 | 0.87[AMR][1000 genomes];0.88[EUR][1000 genomes];0.95[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1012446 | chr2:45921682-46737036 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 62 gene(s) | inside rSNPs | diseases |
2 | esv2757795 | chr2:46532812-46874151 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
3 | esv2759046 | chr2:46532812-46874151 | Active TSS Enhancers Flanking Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
4 | esv34650 | chr2:46605659-46818992 | Enhancers Weak transcription ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
5 | esv2756919 | chr2:46614235-46756431 | Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 35 gene(s) | inside rSNPs | diseases |
6 | nsv437435 | chr2:46636967-46763587 | Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
7 | nsv1001902 | chr2:46651624-46675665 | Enhancers Weak transcription Bivalent Enhancer Genic enhancers Active TSS ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
8 | nsv997637 | chr2:46651624-46676628 | Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
9 | nsv1003646 | chr2:46651624-46677186 | Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
10 | esv34937 | chr2:46651624-46818586 | Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 36 gene(s) | inside rSNPs | diseases |
11 | nsv581745 | chr2:46660445-46693963 | Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Active TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
12 | nsv9702 | chr2:46668106-46745740 | Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:46657200-46672200 | Enhancers | HepG2 | liver |
2 | chr2:46662200-46678400 | Weak transcription | Placenta | Placenta |
3 | chr2:46663200-46671400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr2:46667000-46688400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr2:46668000-46670000 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr2:46668000-46670600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr2:46668200-46683600 | Weak transcription | K562 | blood |
8 | chr2:46669600-46669800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
9 | chr2:46669600-46670000 | Enhancers | Gastric | stomach |
10 | chr2:46669600-46670200 | Enhancers | Pancreas | Pancrea |
11 | chr2:46669600-46671400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |